More effective cell therapies for more cancer patients
Critically ill cancer patients are now struggling to access cell therapies like CAR-T, and when they do, they don’t work as well as they could
We’re empowering cancer patients with a new option to bank their immune cells for future cell therapy
How do we do it?
We reach cancer patients earlier in their treatment journey and offer them the option to store their immune cells at no cost to them.
We collect and store the cells in a way that should be acceptable for future cell therapy manufacturing. Patients can participate knowing that they are taking an action proactively that meaningfully improves their outlook.
Benefits for all
Patients get an early, free option that may streamline their access to a cell therapy option relevant to their diagnosis.
Doctors no longer have to watch a patient’s chances to get a cell therapy evaporate as the cancer progresses and standard of care fails them.
Cell therapy innovators have new, unprecedented access to patients and their cells to accelerate trial enrollment and boost outcomes.